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ABSTRACT
Background: One of the causes of upper gastrointestinal bleeding in patients with liver cirrhosis is the 
presence of portal hypertensive gastropathy (PHG). The prevalence of PHG in patients with liver cirrhosis is 
quite high but there is still inconsistency regarding the studies about gastric pH in cirrhosis patient. The aim of 
this study is to compare the gastric pH in mild and severe PHG due to liver cirrhosis.
Method: Cross sectional method with consecutive sampling was done to all liver cirrhotic patients who came 
to Clinic of Gastroenterology and Hepatology in Cipto Mangunkusumo hospital from March to May 2014. Sixty 
two patients with portal hypertensive gastropathy underwent endoscopy to measure the degree of gastropathy 
????????? ?????????????????????????????????????????????????????????????????????
Results: There are 50 (80.6%) male patients and 12 (19.4%) female patients participated in this study. Portal 
hypertensive gastropathy is mostly caused by hepatitis C (56.5%), hepatitis B (32.3%), non-hepatitis (8.1%) and 
alcohol (3.2%). The mean of gastric pH in all liver cirrhosis patients with portal hypertensive gastropathy was 2.13. 
The mean gastric pH in liver cirrhosis patient with mild portal hypertensive gastropathy (2.00 mEq/L) was lower 
???????????????????????????????????????????????????????????????????? ?????? ?????????????????????????????? ???????
Conclusion: The gastric pH in liver cirrhosis patient between mild and severe portal hypertensive gastropathy 
???????????????????????????
Keywords: gastric pH, liver cirrhosis, portal hypertensive gastropathy, pH-metric
ABSTRAK
Latar belakang: Salah satu penyebab perdarahan saluran cerna pada pasien dengan sirosis adalah adanya 
gastropati hipertensi portal. Prevalensi gastropati hipertensi portal pada pasien sirosis cukup tinggi tetapi masih 
terdapat inkonsistensi dalam studi mengenai pH lambung pada pasien sirosis. Tujuan penelitian ini adalah untuk 
membandingkan pH lambung pada gastropati hipertensi portal ringan dan berat akibat sirosis hati.
Metode: Penelitian ini menggunakan metode potong lintang dengan pengambilan sampel secara konsekutif 
terhadap semua pasien sirosis di poliklinik gastroenterologi dan hepatologi di Rumah Sakit Cipto Mangunkusumo 
pada Maret hingga Mei 2014. Enam puluh dua pasien dengan gastropati hipertensi portal menjalani endoskopi 
untuk mengukur derajat gastropati berdasarkan klasifikasi McCormack dan rerata pH lambung basal 
menggunakan pH meter.
Hasil: Terdapat 50 (80,6%) pasien laki-laki dan 12 (19,4%) pasien perempuan yang berpartisipasi dalam 
penelitian ini. Gastropati hipertensi portal sebagian besar disebabkan oleh hepatitis C (56,5%), hepatitis B 
(32,35), non-hepatitis (8,15), dan alkohol (3,2%). Rerata pH lambung pada pasien sirosis dengan gastropati 
hipertensi portal ringan (2,00 mEq/L) lebih rendah dibandingkan gastropati hipertensi portal berat (2,25 mEq/L) 
???????????????????????????????????
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Simpulan: Terdapat perbedaan yang bermakna antara pH lambung gastropati hipertensi portal ringan dan 
berat pada pasien sirosis.
 
Kata kunci: pH lambung, sirosis hati, gastropati hipertensi portal, pH meter
INTRODUCTION
Upper gastrointestinal bleeding in patients with 
liver cirrhosis is caused by several factors such as 
peptic ulcer, esophageal varices, and the presence 
of portal hypertensive gastropathy (PHG).??? Portal 
hypertensive gastropathy is a term used to describe 
endoscopic gastric mucosa characterized by mosaic-
like pattern with or without red spots, which is most 
likely found in patients with cirrhotic or non-cirrhotic 
portal hypertension. The prevalence rate of PHG, 
???? ????????? ??????? ????????????? ???? ???????????
??? ???? ??????? ???? ??? ?????? ?????? ????????? ????
??? ?????????????? ???????4 The incidence of acute 
bleeding due to PHG is extremely low and generally 
occurs in severe PHG, while the prevalence of chronic 
??????????????????????????????????????????????????
???????????????????????????????????????????????
et al reported an increased prevalence of gastric 
ulcers in patients with portal hypertension in liver 
cirrhosis compared to the normal population, with the 
????????????????????????????????????????????????????
in Japan and West countries.1
Recently, the use of proton pump inhibitor (PPI) is 
greatly increased. These drugs are a class of drugs that 
are highly effective in inhibiting gastric acid secretion, 
and their usage is increasing in diseases associated 
with gastric acid. This class of drugs also widely 
used in patients with cirrhosis of the liver, with the 
main objective to prevent complications of the peptic 
ulcer in patients with esophageal varices or in PHG 
patients treated with multiple drugs.5 The report on the 
??????????????????????????????????????????????????????
in patients with liver cirrhosis is scarce. Some studies 
reported that gastric acid secretion in patients with liver 
???????????????????????? ????? ??????????????????????????
normal gastric acid secretion. Whereas in experiments 
using dogs reported an increased production of acid 
production in cholestasis, hepatocellular injury and 
collateral portal-systemic circulation.6,7 These studies 
take measurements of gastric acid in the basal state 
or by stimulation of acid secretion.5,6,7 Savarino et 
al conducted a study to evaluate the gastric acid in 
patients with liver cirrhosis for 24 hours and concluded 
???????????????????????????????????????????????????????????
patients with liver cirrhosis than in control.? Acidity in 
?????????????????????????????????????????????????????
at night, with no difference at any other time. Gastric 
acidity in patients with liver cirrhosis with PHG is 
??????????????????????????? ????????????? ????????????
Due to inconsistency in studies related with gastric 
pH in patients with liver cirrhosis, while the use 
of proton pump inhibitors become routine in liver 
cirrhosis patients with or without PHG, it is necessary 
to conduct a study on gastric pH in patients with liver 
cirrhosis in relation with the degree of PHG. The aim 
???????????????????????????????????????????????????????
mean differences in patient with mild and severe PHG 
caused by liver cirrhosis. The hypothesis of this study 
is that the gastric pH in patient with mild PHG is lower 
than the gastric pH in patient with severe PHG.
METHOD
This is a cross-sectional study conducted in Cipto 
Mangunkusumo Hospital from March to May 2014. 
The general population in this study is all patient with 
PHG caused by liver cirrhosis. Expected population is 
all patient that visit Cipto Mangunkusumo Hospital as 
an outpatient or inward patients. The study participant 
was obtained from expected population consecutively.
Inclusion criteria for this study are liver cirrhosis 
????????????????????????????? ????????????? ?????????
for this study and through endoscopy. Exclusion 
criteria are patients with hepatic coma, malignancy, 
PHG caused by liver cirrhosis who consumes PPI 
less than a week or H2 receptor antagonist less 
????? ?????? ????? ??????? ????????? ?????????????? ?????
as diabetes mellitus with uncontrolled blood sugar, 
severe infection, sepsis, kidney failure, consumption 
of histamine drug and uncooperative patient. Patients 
whose consent were taken, underwent endoscopy to 
assess the degree of PHG, and were measured with 
pH-metric. The acquired data were analyzed with SPSS 
22.0. This study was already given ethical clearance 
from Ethical Committee from Faculty of Medicine, 
University of Indonesia.
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RESULTS ??????????????????????????????????????????????????????
This result is concordance with primary cause of liver 
cirrhosis in Indonesia which dominated by hepatitis 
B and hepatitis C.11The same result also shown in 
United States that most cirrhosis caused by hepatitis 
C and non alcoholic steatohepatitis (NASH). In East 
countries and South East Asia, hepatitis B is endemic 
disease as well as in North Africa, Egypt, and Middle 
East Country. In Egypt, Sudan, South Africa and Sub 
Sahara, Caribbean and South America, schistosomiasis 
is also an important caused of liver cirrhosis.11 
Most study assumed the degree of gastropathy 
is mostly correlated with the degree of Child Pugh 
score.12???????????????????????????????????????????????????
in degree of PHG caused by cirrhosis based on the 
????????????????????????????????????????????????????
the amount of subject in this study that was inadequate 
to assess this differences. In addition, most subjects 
who had Child Pugh A also has severe PHG. Most 
subjects were consuming propranolol which can 
amend the degree of PHG. Corresponding with the 
randomized controlled study by Hosking et al in 24 
patient with PHG with clinically esophageal varices 
and PHG who were diagnosed at least 6 weeks before 
the study, were given propranolol 160 mg once daily 
or placebo 6 weeks continuously, then crossover in 6 
weeks to assess the reduction of bleeding, increasing 
hemoglobin and the changing in mucosal lesion 
after endoscopy compared to placebo, even when 
???????????????????????????????
????????????????????????????? ???????? ???????????
propranolol to prevent re-bleeding in patients with 
cirrhosis of the liver due to severe PHG. Random 
controlled studies in patients with acute and chronic 
bleeding due to PHG given propranolol (26 patients) 
and were not given any treatment is only given iron 
???????????? ??? ?????????? ???????????????????????????
goal of the mentioned study was to assess the presence 
??????????????????????????????????????????????????????
the presence of acute upper gastrointestinal bleeding 
known from a decrease in hematocrit and a picture of 
the red spots on the gastric as the source of bleeding 
in emergency endoscopic examination performed in 
????????? ????????????? ???????????????? ??????????????
????????????????? ?????????????????????????? ?????????
which need three or more packed red cell transfusion 
in three months or need ferron supplementation 
continuously. The study conclude that patient who 
administered propranolol was free from re-bleeding 
more than patient who given the placebo, whether acute 
????????? ????????? ????? ??? ???????? ????????? ?????
Table 1. General characteristics of patients
Variable n (%)
Age (mean) 53.39 ± 9.850
Sex
Male 50 (80.6)
Female 12 (19.4)
Ethnic
Javanese 21 (33.9)
Sundanesse 8 (12.9)
Betawi 16 (25.8)
Outside Javanese 17 (27.4)
Degree of PHG
Severe 38 (61.3)
Mild 24 (38.7)
Caused of liver cirrhosis
Hepatitis B 20 (32.3)
Hepatitis C 35 (56.5)
Non hepatitis 5 (8.1)
Alcohol 2 (3.2)
Child Pugh
A 33 (53.2)
B 9 (14.5)
C 20 (32.3)
PHG: portal hypertensive gastropathy 
There were 67 cirrhosis patients in the study period, 
?????????????????????????????????? ????????????????
ovarium tumor metastases and 2 patients refused in 
having gastric pH measurement due to unbearable 
feeling at insertion of the equipment through nose. The 
??????????????????????????????????????????????????????
???????????????????????????????????????????
Before being analyzed, the data was assessed 
their normality with Kolmogorov-Smirnov method. 
The data was normally distributed and therefore was 
analyzed with T-test independent to measure mean 
differences of gastric pH between mild PHG and 
????????????????????????????????????????????????????
stated in Table 2.
Table 2. Mean differences of gastric pH between mild and 
severe PHG
Variable
PHG
p
Severe Mild
pH 2.25(mean = 0.55)
2.00 
(mean = 0.37) 0.035
PHG: portal hypertensive gastropathy 
DISCUSSION
The subject of this study was predominantly male 
????????????????????????????????????????????????????
This ratio is higher than the general ratio in liver 
??????????????????????????9,10  This difference is due to the 
subject of this study which is PHG patient caused by 
liver cirrhosis. Primary cause of liver cirrhosis in this 
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??????????????????????????????? ?????????????????????
?????????????14
The mean gastric pH in normal population is less 
????????????????????????????????????????????????????
???? ????????? ??? ??????????????????????? ?????????
???????????????????????????????????????????????????
????????????????????????????????????????????????????
???????????? ???? ?????????????? ??????????? ????? ????????
These results is accordance with report from Savarino 
et al who measured mean gastric pH within 24 hours 
and obtained gastric pH in liver cirrhosis patient with 
???????? ?? ?????????? ?????? ??????? ????? ?????? ??? ???
?????????????????????????????????????????????????????
without PHG caused by liver cirrhosis.??
The mean gastric pH differences in mild and severe 
???????????? ??? ????????????????????????????????????????
This supporting evidence from Scobie et al obtained 
a decrease secretion in gastric acid among cirrhosis 
patient whether basal acid output or maximum acid 
output. This condition is correlated with increasing 
ulcer incident among liver cirrhosis and the role of 
???????????? ?????? ??? ????????????????? ????????? ???
esophageal varices.15 By using spectrophotometry, 
?? ???????????????? ??? ????????????? ??????????????????
mucosal perfusion in antrum among severe PHG 
patient compared to control and mild PHG patient, 
?????? ?????? ??? ??????????? ??????????????????????????
perfusion in corpus in patient with severe PHG 
compared to mild and control.16
Another study described that straight arterial and 
dilatation found mainly in precapiller, capiller, and 
veins in submucosa and subserous in patients with liver 
cirrhosis. This morphology decrease arteriovenous 
gastric resistance among liver cirrhosis patient.14 
Aside from the mucosal damage and disturbance of 
????????????????????????????????????????????????????????
reduction in gastric mucosal oxygenation in tested 
animal with portal hypertension. Gastric mucosal 
oxygenation is more reduced with aspirin and more 
susceptible to gastric damage. This proves that mucosal 
damage in portal hypertension was a consequence of 
oxygenation damage in gastric mucosa.17
????????????????????????????????????? ??????????????
reduction in the amount of parietal in mice with portal 
hypertension than in control. Elevation of gastric pH in 
liver cirrhosis with PHG shown that mucosal damage 
was not caused by aggressive factor, but it decreased 
the defensive gastric mucous due to disturbance of 
microcirculation gastric mucous, reducing oxygenation 
and blood stream to gastric mucous.??
Reduction of defensive factor which causes the 
gastric mucosa became very vulnerable to the damage 
is caused by aggressive factors such as bile acid, aspirin 
and alcohol. Some studies showed PHG is a risk factor 
for the occurrence of peptic ulcer. Until now there has 
been no clear pathogenesis of peptic ulcers in cirrhosis 
patients.5
This study shows that there are mean differences 
in gastric pH between mild to severe PHG patients 
that showed the damage to the gastric mucosa due to 
PHG is a major factor pH changes in patients with 
liver cirrhosis. Changes in gastric pH is very likely an 
attempt to protect from gastric mucosal damage due 
to various changes in the area of the gastric mucosa, 
so that the heavier PHG, gastric pH will increase, but 
this assumption must be proven by further study to 
assess the effectiveness of the increase in gastric pH 
in an effort to protect the gastric mucous.
This study used homogeneous sample of subjects 
with PHG due to liver cirrhosis that were categorized 
into mild and severe according to the McCormack 
criteria. In an effort to minimize the factors that may 
affect the results of measurements, the whole subject 
has been freed from PPI medications and drugs that 
are likely to affect the pH of the stomach. Meanwhile, 
to minimize bias against the degrees of PHG, the 
??????????????????????????????????????????????????
by a consultant in charge in Digestive Endoscopy 
Center, Cipto Mangunkusumo Hospital. The study that 
distinguish the degree of PHG in liver cirrhosis have 
never been performed and the pathogenesis of gastric 
pH changes in patients with cirrhosis due PHG is still 
uncertain. Therefore, by assessing the mean gastric 
pH differences between mild and severe PHG due to 
cirrhosis, an insight of the pathogenesis of gastric pH 
changes in patients PHG due to liver cirrhosis would 
be uncovered. This study did not asses gastrin levels, 
which are the main role in the mechanism of gastric 
acid secretion due to the constraints on time and cost 
factors of this study.
CONCLUSION 
The mean gastric pH in mild PHG patients due 
to liver cirrhosis is lower than the mean gastric pH 
in severe PHG patients due to liver cirrhosis. It is 
necessary to conduct further study on the effectiveness 
of the use of PPIs in liver cirrhosis patient with PHG 
in preventing peptic ulcer and upper gastrointestinal 
bleeding.
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